Industry Research Reports

Home > Reports > Medical Devices & Consumables > Heart Lung (Cardiopulmonary) Bypass Machine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Heart Lung (Cardiopulmonary) Bypass Machine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 101 Pages

Report ld: 3482179

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Heart Lung (Cardiopulmonary) Bypass Machine Market Size(US$)

CAGR 2025-2031

4.5%

Market Size,2031

USD 382

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 293 million

Market Forecast in 2031(Value)

US$ 382 million

CAGR

4.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Heart Lung (Cardiopulmonary) Bypass Machine was estimated to be worth US$ 282 million in 2024 and is forecast to a readjusted size of US$ 382 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.

Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient"s blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.

The Cardiopulmonary Bypass Machine market is primarily driven by the increasing prevalence of cardiovascular diseases and the growing demand for advanced surgical procedures. As heart surgeries become more intricate and the complexity of cases rises, the need for reliable and sophisticated cardiopulmonary bypass machines is on the rise. These machines play a crucial role in maintaining circulation and oxygenation during cardiac surgeries, enabling surgeons to perform intricate procedures with precision. Moreover, technological advancements have led to the development of innovative features in these machines, such as improved monitoring, minimized blood trauma, and reduced risk of complications. However, the market also faces challenges, including the high cost of these machines and the need for skilled healthcare professionals to operate them effectively. Regulatory compliance and safety considerations also present challenges for manufacturers. To succeed, stakeholders must focus on continuous innovation, addressing cost concerns through efficient manufacturing processes, and providing comprehensive training and support to healthcare teams. Collaborating with medical institutions to understand their specific needs and enhancing patient outcomes through improved machine performance will drive market growth and the adoption of cardiopulmonary bypass machines.

This report aims to provide a comprehensive presentation of the global market for Heart Lung (Cardiopulmonary) Bypass Machine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Heart Lung (Cardiopulmonary) Bypass Machine by region & country, by Type, and by Application.

The Heart Lung (Cardiopulmonary) Bypass Machine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heart Lung (Cardiopulmonary) Bypass Machine.

MARKET SEGMENTATION

By Company

LivaNova
Getinge
Medtronic
Terumo
Braile Biomedica
Tianjin Medical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Single Roller Pump
Double Roller Pump

Segment by Application

Cardiac Surgery
Lung Transplant Operation
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Heart Lung (Cardiopulmonary) Bypass Machine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Heart Lung (Cardiopulmonary) Bypass Machine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Heart Lung (Cardiopulmonary) Bypass Machine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Heart Lung (Cardiopulmonary) Bypass Machine Product Introduction

1.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Market Size Forecast

1.2.1 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value (2020-2031)

1.2.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume (2020-2031)

1.2.3 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Price (2020-2031)

1.3 Heart Lung (Cardiopulmonary) Bypass Machine Market Trends & Drivers

1.3.1 Heart Lung (Cardiopulmonary) Bypass Machine Industry Trends

1.3.2 Heart Lung (Cardiopulmonary) Bypass Machine Market Drivers & Opportunity

1.3.3 Heart Lung (Cardiopulmonary) Bypass Machine Market Challenges

1.3.4 Heart Lung (Cardiopulmonary) Bypass Machine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Heart Lung (Cardiopulmonary) Bypass Machine Players Revenue Ranking (2024)

2.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Revenue by Company (2020-2025)

2.3 Global Heart Lung (Cardiopulmonary) Bypass Machine Players Sales Volume Ranking (2024)

2.4 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Company Players (2020-2025)

2.5 Global Heart Lung (Cardiopulmonary) Bypass Machine Average Price by Company (2020-2025)

2.6 Key Manufacturers Heart Lung (Cardiopulmonary) Bypass Machine Manufacturing Base and Headquarters

2.7 Key Manufacturers Heart Lung (Cardiopulmonary) Bypass Machine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Heart Lung (Cardiopulmonary) Bypass Machine

2.9 Heart Lung (Cardiopulmonary) Bypass Machine Market Competitive Analysis

2.9.1 Heart Lung (Cardiopulmonary) Bypass Machine Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Heart Lung (Cardiopulmonary) Bypass Machine Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Lung (Cardiopulmonary) Bypass Machine as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Single Roller Pump

3.1.2 Double Roller Pump

3.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type

3.2.1 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, by Type (2020-2031)

3.2.3 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, by Type (%) (2020-2031)

3.3 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Type

3.3.1 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume, by Type (2020-2031)

3.3.3 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume, by Type (%) (2020-2031)

3.4 Global Heart Lung (Cardiopulmonary) Bypass Machine Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cardiac Surgery

4.1.2 Lung Transplant Operation

4.1.3 Other

4.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application

4.2.1 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, by Application (2020-2031)

4.2.3 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, by Application (%) (2020-2031)

4.3 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Application

4.3.1 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume, by Application (2020-2031)

4.3.3 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume, by Application (%) (2020-2031)

4.4 Global Heart Lung (Cardiopulmonary) Bypass Machine Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region

5.1.1 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region (2020-2025)

5.1.3 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region (2026-2031)

5.1.4 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region (%), (2020-2031)

5.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Region

5.2.1 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Region (2020-2025)

5.2.3 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Region (2026-2031)

5.2.4 Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Region (%), (2020-2031)

5.3 Global Heart Lung (Cardiopulmonary) Bypass Machine Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

5.4.2 North America Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

5.5.2 Europe Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

5.6.2 Asia Pacific Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

5.7.2 South America Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

5.8.2 Middle East & Africa Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Heart Lung (Cardiopulmonary) Bypass Machine Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Heart Lung (Cardiopulmonary) Bypass Machine Sales Value

6.2.1 Key Countries/Regions Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

6.2.2 Key Countries/Regions Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

6.3.2 United States Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

6.4.2 Europe Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

6.5.2 China Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

6.5.3 China Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

6.6.2 Japan Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

6.7.2 South Korea Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

6.8.2 Southeast Asia Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020-2031

6.9.2 India Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

6.9.3 India Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 LivaNova

7.1.1 LivaNova Company Information

7.1.2 LivaNova Introduction and Business Overview

7.1.3 LivaNova Heart Lung (Cardiopulmonary) Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 LivaNova Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

7.1.5 LivaNova Recent Development

7.2 Getinge

7.2.1 Getinge Company Information

7.2.2 Getinge Introduction and Business Overview

7.2.3 Getinge Heart Lung (Cardiopulmonary) Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Getinge Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

7.2.5 Getinge Recent Development

7.3 Medtronic

7.3.1 Medtronic Company Information

7.3.2 Medtronic Introduction and Business Overview

7.3.3 Medtronic Heart Lung (Cardiopulmonary) Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Medtronic Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

7.3.5 Medtronic Recent Development

7.4 Terumo

7.4.1 Terumo Company Information

7.4.2 Terumo Introduction and Business Overview

7.4.3 Terumo Heart Lung (Cardiopulmonary) Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Terumo Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

7.4.5 Terumo Recent Development

7.5 Braile Biomedica

7.5.1 Braile Biomedica Company Information

7.5.2 Braile Biomedica Introduction and Business Overview

7.5.3 Braile Biomedica Heart Lung (Cardiopulmonary) Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Braile Biomedica Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

7.5.5 Braile Biomedica Recent Development

7.6 Tianjin Medical

7.6.1 Tianjin Medical Company Information

7.6.2 Tianjin Medical Introduction and Business Overview

7.6.3 Tianjin Medical Heart Lung (Cardiopulmonary) Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Tianjin Medical Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

7.6.5 Tianjin Medical Recent Development

8 Industry Chain Analysis

8.1 Heart Lung (Cardiopulmonary) Bypass Machine Industrial Chain

8.2 Heart Lung (Cardiopulmonary) Bypass Machine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Heart Lung (Cardiopulmonary) Bypass Machine Sales Model

8.5.2 Sales Channel

8.5.3 Heart Lung (Cardiopulmonary) Bypass Machine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Heart Lung (Cardiopulmonary) Bypass Machine Market Trends

Table 2. Heart Lung (Cardiopulmonary) Bypass Machine Market Drivers & Opportunity

Table 3. Heart Lung (Cardiopulmonary) Bypass Machine Market Challenges

Table 4. Heart Lung (Cardiopulmonary) Bypass Machine Market Restraints

Table 5. Global Heart Lung (Cardiopulmonary) Bypass Machine Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Heart Lung (Cardiopulmonary) Bypass Machine Revenue Market Share by Company (2020-2025)

Table 7. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Company (2020-2025) & (K Units)

Table 8. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Heart Lung (Cardiopulmonary) Bypass Machine Price by Company (2020-2025) & (US$/Unit)

Table 10. Key Manufacturers Heart Lung (Cardiopulmonary) Bypass Machine Manufacturing Base and Headquarters

Table 11. Key Manufacturers Heart Lung (Cardiopulmonary) Bypass Machine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Heart Lung (Cardiopulmonary) Bypass Machine

Table 13. Global Heart Lung (Cardiopulmonary) Bypass Machine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Lung (Cardiopulmonary) Bypass Machine as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Market Share in Value by Type (2020-2025)

Table 20. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Market Share in Value by Type (2026-2031)

Table 21. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Type (2020-2025) & (K Units)

Table 23. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Type (2026-2031) & (K Units)

Table 24. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Heart Lung (Cardiopulmonary) Bypass Machine Price by Type (2020-2025) & (US$/Unit)

Table 27. Global Heart Lung (Cardiopulmonary) Bypass Machine Price by Type (2026-2031) & (US$/Unit)

Table 28. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Market Share in Value by Application (2020-2025)

Table 32. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Market Share in Value by Application (2026-2031)

Table 33. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)

Table 34. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Application (2020-2025) & (K Units)

Table 35. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Application (2026-2031) & (K Units)

Table 36. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Heart Lung (Cardiopulmonary) Bypass Machine Price by Application (2020-2025) & (US$/Unit)

Table 39. Global Heart Lung (Cardiopulmonary) Bypass Machine Price by Application (2026-2031) & (US$/Unit)

Table 40. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region (2020-2025) & (%)

Table 44. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region (2026-2031) & (%)

Table 45. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Region (K Units): 2020 VS 2024 VS 2031

Table 46. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Region (2020-2025) & (K Units)

Table 47. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Region (2026-2031) & (K Units)

Table 48. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Region (2020-2025) & (%)

Table 49. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Region (2026-2031) & (%)

Table 50. Global Heart Lung (Cardiopulmonary) Bypass Machine Average Price by Region (2020-2025) & (US$/Unit)

Table 51. Global Heart Lung (Cardiopulmonary) Bypass Machine Average Price by Region (2026-2031) & (US$/Unit)

Table 52. Key Countries/Regions Heart Lung (Cardiopulmonary) Bypass Machine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume, (2020-2025) & (K Units)

Table 56. Key Countries/Regions Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume, (2026-2031) & (K Units)

Table 57. LivaNova Company Information

Table 58. LivaNova Introduction and Business Overview

Table 59. LivaNova Heart Lung (Cardiopulmonary) Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 60. LivaNova Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

Table 61. LivaNova Recent Development

Table 62. Getinge Company Information

Table 63. Getinge Introduction and Business Overview

Table 64. Getinge Heart Lung (Cardiopulmonary) Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 65. Getinge Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

Table 66. Getinge Recent Development

Table 67. Medtronic Company Information

Table 68. Medtronic Introduction and Business Overview

Table 69. Medtronic Heart Lung (Cardiopulmonary) Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 70. Medtronic Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

Table 71. Medtronic Recent Development

Table 72. Terumo Company Information

Table 73. Terumo Introduction and Business Overview

Table 74. Terumo Heart Lung (Cardiopulmonary) Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Terumo Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

Table 76. Terumo Recent Development

Table 77. Braile Biomedica Company Information

Table 78. Braile Biomedica Introduction and Business Overview

Table 79. Braile Biomedica Heart Lung (Cardiopulmonary) Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Braile Biomedica Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

Table 81. Braile Biomedica Recent Development

Table 82. Tianjin Medical Company Information

Table 83. Tianjin Medical Introduction and Business Overview

Table 84. Tianjin Medical Heart Lung (Cardiopulmonary) Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. Tianjin Medical Heart Lung (Cardiopulmonary) Bypass Machine Product Offerings

Table 86. Tianjin Medical Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Heart Lung (Cardiopulmonary) Bypass Machine Downstream Customers

Table 90. Heart Lung (Cardiopulmonary) Bypass Machine Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Heart Lung (Cardiopulmonary) Bypass Machine Product Picture

Figure 2. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume (2020-2031) & (K Units)

Figure 5. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Price (2020-2031) & (US$/Unit)

Figure 6. Heart Lung (Cardiopulmonary) Bypass Machine Report Years Considered

Figure 7. Global Heart Lung (Cardiopulmonary) Bypass Machine Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Heart Lung (Cardiopulmonary) Bypass Machine Players Sales Volume Ranking (2024) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Heart Lung (Cardiopulmonary) Bypass Machine Revenue in 2024

Figure 10. Heart Lung (Cardiopulmonary) Bypass Machine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Single Roller Pump Picture

Figure 12. Double Roller Pump Picture

Figure 13. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)

Figure 16. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Heart Lung (Cardiopulmonary) Bypass Machine Price by Type (2020-2031) & (US$/Unit)

Figure 18. Product Picture of Cardiac Surgery

Figure 19. Product Picture of Lung Transplant Operation

Figure 20. Product Picture of Other

Figure 21. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)

Figure 24. Global Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Heart Lung (Cardiopulmonary) Bypass Machine Price by Application (2020-2031) & (US$/Unit)

Figure 26. North America Heart Lung (Cardiopulmonary) Bypass Machine Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Heart Lung (Cardiopulmonary) Bypass Machine Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Heart Lung (Cardiopulmonary) Bypass Machine Sales Volume (%), (2020-2031)

Figure 38. United States Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application (%), 2024 VS 2031

Figure 44. China Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

Figure 46. China Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application (%), 2024 VS 2031

Figure 56. India Heart Lung (Cardiopulmonary) Bypass Machine Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Type (%), 2024 VS 2031

Figure 58. India Heart Lung (Cardiopulmonary) Bypass Machine Sales Value by Application (%), 2024 VS 2031

Figure 59. Heart Lung (Cardiopulmonary) Bypass Machine Industrial Chain

Figure 60. Heart Lung (Cardiopulmonary) Bypass Machine Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Heart Lung (Cardiopulmonary) Bypass Machine in 2031? zhanKai

The global market size of Heart Lung (Cardiopulmonary) Bypass Machine in 2031 was 382 Million USD.

What was the global market size of Heart Lung (Cardiopulmonary) Bypass Machine in 2025? shouQi

Which companies rank high in the global Heart Lung (Cardiopulmonary) Bypass Machine market? shouQi

What is the annual compound growth rate of the global Heart Lung (Cardiopulmonary) Bypass Machine market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Heart Lung (Cardiopulmonary) Bypass Machine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heart Lung (Cardiopulmonary) Bypass Machine was estimated to be worth US$ 293 million in 2025 and is projected to reach US$ 398 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 135
USD 3950.00
(Single User License)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Research Report 2026
The global Heart Lung (Cardiopulmonary) Bypass Machine market was valued at US$ 293 million in 2025 and is anticipated to reach US$ 398 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 108
USD 2900.00
(Single User License)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heart Lung (Cardiopulmonary) Bypass Machine market is projected to grow from US$ 282 million in 2024 to US$ 382 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 136
USD 4900.00
(Single User License)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Research Report 2025
The global market for Heart Lung (Cardiopulmonary) Bypass Machine was valued at US$ 282 million in the year 2024 and is projected to reach a revised size of US$ 382 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published Date: 2025-01-16
Pages: 84
USD 2900.00
(Single User License)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Insights, Forecast to 2030
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published Date: 2024-04-12
Pages: 93
USD 4900.00
(Single User License)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Research Report 2024
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published Date: 2024-01-12
Pages: 78
USD 2900.00
(Single User License)
Heart Lung (Cardiopulmonary) Bypass Machine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published Date: 2024-01-08
Pages: 104
USD 3950.00
(Single User License)

Heart Lung (Cardiopulmonary) Bypass Machine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heart Lung (Cardiopulmonary) Bypass Machine was estimated to be worth US$ 293 million in 2025 and is projected to reach US$ 398 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 135
USD 3950.00 (Single User License)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Research Report 2026
The global Heart Lung (Cardiopulmonary) Bypass Machine market was valued at US$ 293 million in 2025 and is anticipated to reach US$ 398 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-04-17
Pages: 108
USD 2900.00 (Single User License)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heart Lung (Cardiopulmonary) Bypass Machine market is projected to grow from US$ 282 million in 2024 to US$ 382 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 136
USD 4900.00 (Single User License)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Research Report 2025
The global market for Heart Lung (Cardiopulmonary) Bypass Machine was valued at US$ 282 million in the year 2024 and is projected to reach a revised size of US$ 382 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published: 2025-01-16
Pages: 84
USD 2900.00 (Single User License)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Insights, Forecast to 2030
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published: 2024-04-12
Pages: 93
USD 4900.00 (Single User License)
Global Heart Lung (Cardiopulmonary) Bypass Machine Market Research Report 2024
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published: 2024-01-12
Pages: 78
USD 2900.00 (Single User License)
Heart Lung (Cardiopulmonary) Bypass Machine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published: 2024-01-08
Pages: 104
USD 3950.00 (Single User License)